Agenda

8:00 AM
State of the Art of Hematology: Emerging Therapies
Ruemu E. Birhiray, MD - Chair
CEO, Indy Hematology Education Inc.,
Partner and Vice President, Hematology Oncology of Indiana, PC
(Indianapolis, IN) 

8:30 AM
Multiple Myeloma
Kenneth Anderson, MD
Kraft Family Professor of Medicine, Harvard Medical School
Chief, Division of Hematologic Neoplasia
Dana-Farber Cancer Institute
(Boston, MA)
 

9:00 AM
Benign Hematology: 2016 Update
Craig Kessler, MD
Attending Hematologist-Oncologist,
Medstar Georgetown University Hospital,
Professor of Medicine and Pathology
Departments of Medicine and Pathology
Georgetown University Medical Center
(Washington, DC)


9:30 AM
Chronic Myeloid Leukemia: Current and Emerging Therapies
Charles Schiffer, MD
Professor of Oncology and Medicine,
Head, Multidisciplinary Leukemia/Lymphoma Team,
Director, Fellowship Program, Division of Hematology/Oncology
Wayne State University School of Medicine
(Detroit, MI)

10:00 AM
Chronic Lymphocytic Leukemia: State of the Art; Targets, Antibodies, Activity and Resistance
Thomas Kipps, MD
Professor of Medicine
Deputy Director of Research Operations
UC San Diego Moores Cancer Center
(San Diego, CA)


10:30 AM
Break and Q&A

10:45 AM
Indolent Lymphomas and Hodgkin's Lymphoma
Sonali Smith, MD
Associate Professor, Section of Hematology/Oncology
Director, Lymphoma Program, University of Chicago
(Chicago, IL)


11:15 AM
Aggressive B and T Cell Lymphomas
John Leonard, MD
Attending Physician, New York-Presbyterian Hospital, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Weill Cornell Medical College
(New York, NY)


11:45 AM
Not so Benign Hematology: Diagnosis and Treatment of Complementopathies and Aplastic Anemia
Robert Brodsky, MD
Director, Division of Hematology
Professor of Medicine and Oncology
The Johns Hopkins Family Professor
Johns Hopkins Medicine
(Baltimore, MD) 


12:15 PM
T. HOWARD LEE KEY NOTE LECTURE
Checking and Pointing the Way Forward in Hematologic Malignancies: Immune Check Point Inhibitors
Stephen Ansell, MD
Professor of Medicine
Mayo Clinic
(Rochester, MN) 

 
1:00 PM
Q & A

1:15 PM
Lunch

2:00 PM
Hematologic Malignancy Immunotherapy: CAR-T Cells and Beyond
Noelle Frey, MD
Assistant Professor of Medicine
Director, Hematology/Oncology Inpatient Nurse Practitioner Service, Hospital of the University of Pennsylvania
Associate Director, Bone Marrow Transplant Program, Hospital of the University of Pennsylvania
Perelman School of Medicine University of Pennsylvania
(Philadelphia, PA)

2:30 PM
Waldenström's Macroglobulinemia: Molecular Diagnosis, Targeted Therapy and Resistance Mechanisms
Steven Treon, MD
Associate Professor, Department of Medicine, Harvard Medical School; Director, Bing Center for Waldenstrom's Macroglobulinemia, Adult Oncology, Dana-Farber Cancer Institute
(Boston, MA)

3:00 PM
Myeloproliferative Disorders: Targeted and Emerging Therapies
Ayalew Tefferi, MD
Professor of Hematology and Internal Medicine,
Mayo Clinic
(Rochester, MN)


3:30 PM
Break / Q & A

3:45 PM
Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia
Richard Stone, MD
Director, Adult Leukemia Program, Dana-Farber Cancer Institute
Attending Physician, Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School (Boston, Mass.)


4:15 PM
Acute Promylelocytic and other Acute Myeloid Leukemias: Emerging and Maturing Therapies
Martin Tallman, MD
Chief, Leukemia Service, Memorial Sloan-Kettering Cancer Center
Weill Cornell Medical College
(New York, NY)


4:45 PM
Hematopoietic Stem Cell Transplantation
Richard Childs, MD
(Bethesda, MD)
  


5:15 PM
Q & A

5:30 PM
Wrap-Up: Closing Remarks

Nursing Symposium Agenda

8:10 AM
Chronic Lymphocytic Leukemia: State of the Art; Targets, Antibodies, Activity and Resistance
Thomas Kipps, MD

9:20 AM
Multiple Myeloma

Kenneth Anderson, MD

9:40 AM
Indolent Lymphomas and Hodgkin's Lymphoma
Sonali Smith, MD

10:10 AM
Break / Q&A

10:20 AM
Not so Benign Hematology: Diagnosis and Treatment of Complementopathies and Aplastic Anemia 
Robert Brodsky, MD

10:40 AM
Benign Hematology: 2016 Update
Craig Kessler, MD

11:10 AM
Acute Promylelocytic and Other Acute Myeloid Leukemias: Emerging and Maturing Therapies
Martin Tallman, MD

11:40 AM
Management of TKI Toxicities in Hematologic Malignancies
Linda Nielsen, NP
Hematology Oncology of Indiana (Indianapolis, Ind.)

12:05 PM
Adjoin - Join Main Program for Keynote Lecture